Announcements Trials

Browse Landscape

Status

Recruiting 2 Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Prostatic Neoplasms 4 Breast Neoplasms 4 Glioma 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Neurofibromatosis 1 2 Head and Neck Neoplasms 2 Glioblastoma 2 Colonic Neoplasms 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Thoracic Spine Neoplasm 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Meningioma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Astrocytoma 1

Interventions

Cisplatin 18 pembrolizumab 12 Paclitaxel 9 Carboplatin 9 Radiotherapy 5 Gemcitabine 4 Fluorodeoxyglucose F18 4 Colposcopy 4 Brachytherapy 4 fludarabine 3 durvalumab 3 Surveys and Questionnaires 3 Radiation 3 Flow Cytometry 3 Cyclophosphamide 3 Biopsy 3 Bevacizumab 3 toripalimab 2 fludarabine phosphate 2 atezolizumab 2 aldesleukin 2 adavosertib 2 Zoledronic Acid 2 Topotecan 2 Nivolumab 2 Neoadjuvant Therapy 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Cervical Neoplasms × Magnetic Resonance Imaging × Clear all

NCT06752135 2024-12-30

HRCC1

Azienda Policlinico Umberto I

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡